Abstract
Theophylline is believed to be largely eliminated from the body by biotransformation in the liver. Using a hepatectomized dog model, we quantitatively assessed the role of the liver in theophylline elimination. The elimination half-life (t½(β)) increased 348% from 9.82±2.39 h in the control group to 43.99±43.53 h in the hepatectomized group of dogs. The serum clearance (Cl(S)) decreased 70% from 0.060±0.017 l/kg/h in the control group to 0.018±0.009 l/kg/h in the hepatectomized group. The volume of distribution (Vd(β)) decreased 10% from 0.81±0.09 l/kg in the control group to 0.73±0.07 l/kg in the hepatectomy group. The mean protein binding of theophylline in dog serum of 9% is low compared to 53–65% in man. In man and the dog, the serum clearance of theophylline is a reasonable reflection of hepatic clearance. Despite the absence of hepatic clearance in the hepatectomized dog, elimination of theophylline continues to a degree.
Similar content being viewed by others
References
Aranda JV, Sitar DS, Parsons WD, Loughnan PM, Neims AH (1976) Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 293: 413–416
Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem 228: 315–323
Cummins LH, Kozak PP Jr, Gillman SA (1977) Erythromycin’s effect on theophylline blood level. Pediatrics 59: 144–145
de Souich P, McLean AJ, Lalka D, Erill S, Gibaldi M (1978) Pulmonary disease and drug kinetics. Clin Pharmacokinet 3: 257–271
Downie, NM, Starry AR (1977) Descriptive and inferential statistics. Harper and Row, New York, p 244
Firor WM, Stinson E Jr (1929) Total extirpation of the dog’s liver in one stage. Bull Johns Hopkins Hosp 44: 138–148
Frank ED, Frank HA, Jacob SW, Fine J (1962) Hepatic blood flow in experimental hemorrhagic shock. Am J Physiol 202: 7–11
Hendeles L, Bighley L, Richardson RH, Hepler CD, Carmichael J (1977) Frequent toxicity from IV aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 11: 12–18
Hendeles L, Weinberger M (1980) Poisoning patients with intravenous theophylline. Am J Hosp Pharm 37: 49–50
Hendeles L, Weinberger M, Bighley L (1978) Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 118: 97–103
Jenne JJ, Nagasawa HT, Thompson RD (1976) Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19: 375–381
Jenne JW, Wyze E, Rood FS, MacDonald FM (1972) Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13: 349–360
Johnson RF, Schenker S, Roberts RK, Desmond PV, Wilkinson GR (1979) Plasma binding of benzodiazepines in man. J Pharm Sci 68: 1320–1322
Jusko WJ, Gardner MJ, Mangione A, Schentag JJ, Koup JR, Vance JW (1979) Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharm Sci 68: 1358–1366
Levy G, Koysooko R (1976) Renal clearance of theophylline in man. J Clin Pharmacol 16: 329–332
Lohman SM, Miech RP (1976) Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther 196: 213–225
Mangione A, Imhoff TE, Lee RV, Shum LY, Jusko WJ (1978) Pharmacokinetics of theophylline in hepatic disease. Chest 73: 616–622
Matthay RA, Matthay MA, Weinberger MM (1976) Grand mal seizure induced by oral theophylline. Thorax 31: 470–471
Metzler CM, Elfring GL, McEwen AJ (1974) A users manual for NONLIN and associated programs. Research Biostatistics, Upjohn Co, Kalamazoo, Michigan
Nielsen-Kudsk F, Magnussen I, Jakobsen P (1978) Pharmacokinetics of theophylline in ten elderly patients. Acta Pharmacol Toxicol [Kbh] 42: 226–234
Pfeifer HJ, Greenblatt DJ (1978) Clinical toxicity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program. Chest 73: 455–459
Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI (1977) Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med 296: 1495–1497
Piafsky KM, Sitar DS, Rangno RE, Ogilvie RI (1977) Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther 21: 310–316
Roberts RK, Wilkinson GR, Branch RA, Schenker S (1978) Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). Gastroenterology 75: 479–485
Sample RHB, Glick MR, Oei JO (1979) The influence of a new, improved theophylline assay procedure on laboratory analyses. J Indiana State Med Assoc 72: 349–352
Shoemaker WC, Van Itallie TB, Walker WF (1959) Measurement of hepatic glucose output and hepatic blood flow in response to glucagon. Am J Physiol 196: 315–318
Wagner JG (1976) Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 4: 443–467
Weinberger M, Hudgel D, Spector S, Chidsey C (1977) Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol 59: 228–231
Wilkinson GR, Schenker S (1976) Effects of liver disease on drug disposition in man. Biochem Pharmacol 25: 2675–2681
Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brashear, R.E., Nelson, R.L., Glick, M.R. et al. The role of the liver in theophylline elimination. Lung 158, 101–109 (1980). https://doi.org/10.1007/BF02713709
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02713709